SCHEMBL7866069

SCHEMBL7866069

COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCO

nearest known ligand 0.82

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 19/20 0.82
KDR P35968 19/20 0.82
FGFR1 P11362 16/20 0.82
FLT4 P35916 11/20 0.82
EGFR P00533 10/20 0.82
EPHB2 P29323 1/20 0.80
FGFR2 P21802 1/20 0.70
FGFR4 P22455 1/20 0.70
FGFR3 P22607 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867708 0.95 FLT1 (0.83) FLT1KDRFGFR1FLT4EGFR
SCHEMBL1468310 0.92 FLT1 (0.85) FLT1KDRFGFR1FLT4EGFR
SCHEMBL7864752 0.91 FLT1 (0.83) FLT1KDRFGFR1FLT4EGFR
SCHEMBL7870684 0.91 FLT1 (0.90) FLT1KDRFGFR1FLT4EGFR
Hydrochloric Acid SCHEMBL7867659 0.90 FLT1 (0.89) FLT1KDRFGFR1FLT4EGFR
SCHEMBL7867151 0.90 FLT1 (1.00) FLT1KDRFGFR1FLT4EGFR
SCHEMBL3012896 0.90 KDR (1.00) FLT1KDRFGFR1FLT4EGFR
SCHEMBL29365791 0.90 KDR (1.00) FLT1KDRFGFR1FLT4EGFR
SCHEMBL1468192 0.89 FLT1 (0.80) FLT1KDRFGFR1FLT4EGFR
SCHEMBL1467939 0.89 KDR (0.83) FLT1KDRFGFR1FLT4EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885198-B1 4-ANILINOQUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2001-12-19 EP disclosed
US-6291455-B1 PRODUCING AN ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY REDUCING EFFECT ZENECA LIMITED (GB) 2001-09-18 US disclosed
EP-0885198-A1 4-ANILINOQUINAZOLINE DERIVATIVES ZENECA LIMITED (GB) 1998-12-23 EP disclosed
WO-1997032856-A1 4-ANILINOQUINAZOLINE DERIVATIVES ZENECA LIMITED (GB) 1997-09-12 WO disclosed